Variant Bio Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Variant Bio's estimated annual revenue is currently $9.1M per year.(i)
  • Variant Bio's estimated revenue per employee is $194,574

Employee Data

  • Variant Bio has 47 Employees.(i)
  • Variant Bio grew their employee count by -2% last year.

Variant Bio's People

NameTitleEmail/Phone
1
VP, Biology ResearchReveal Email/Phone
2
VP Computational GeneticsReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
Chief Operating Officer & Chief Legal OfficerReveal Email/Phone
5
Chief Business OfficerReveal Email/Phone
6
Director FinanceReveal Email/Phone
7
Director BioinformaticsReveal Email/Phone
8
Associate DirectorReveal Email/Phone
9
Co-Founder, Chief Technology Officer, Chief Genomics OfficerReveal Email/Phone
10
Director Medical BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M50%N/AN/A
#2
$0.9M50%N/AN/A
#3
$5.1M3011%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M415%$16MN/A
#7
$1.1M1183%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M8100%N/AN/A
Add Company

What Is Variant Bio?

Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.

keywords:N/A

N/A

Total Funding

47

Number of Employees

$9.1M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Variant Bio News

2022-04-17 - Nilit launches new bio-based Sensil variant

Nilit launches new bio-based Sensil variant ... widely used in the knitting sector, has launched a new variant of its premium Sensil brand.

2022-04-06 - HDT Bio Demonstrates RNA Vaccines Matched to SARS-CoV2 ...

In addition, the animal studies showed that even when not matched against variants, HDT Bio's RNA vaccine protects against lower respiratory...

2022-03-30 - HDT Bio Doses First Healthy Volunteer in US Phase 1 Trial of Next ...

The vaccine targets the Beta variant of SARS-CoV-2 and has a demonstrated ability to provide broad protection against multiple variants of the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.5M47-15%N/A
#2
$6M474%N/A
#3
$10.4M472%N/A
#4
$11.5M47N/AN/A
#5
$5M47-4%$58.3M